Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

IMW 2019 | Genome sequencing in multiple myeloma

Mehmet Samur • 15 Sep 2019
IMW 2019
Multiple Myeloma

Mehmet Samur, PhD, Dana-Farber Cancer Institute, Boston, MA, provides an overview of genome sequencing of noncoding DNA in multiple myeloma (MM) patients with particular reference to translocations in hypodiploid myeloma. Interview recorded at the International Myeloma Workshop (IMW) 2019, held in Boston, MA.

More from Mehmet Samur

1:36
Improving the identification of patients with high-risk multiple myeloma
Mehmet Samur • 10 Dec 2022
1:34
Inherited predispositions to multiple myeloma
Mehmet Samur • 10 Dec 2022
2:37
Genomic factors impacting survival in patients with myeloma without known cytogenetic risk features
Mehmet Samur • 10 Dec 2022
3:00
Processes leading to the development of hyperdiploidy in multiple myeloma
Mehmet Samur • 10 Dec 2022

Related Videos

1:47
Looking forward to the Miami Myeloma MRD Virtual Meeting 2024
Ola Landgren • 13 Apr 2024
2:27
The encouraging results of the LINKER-MM1 trial: safety and efficacy of linvoseltamab in R/R myeloma
Faith Davies • 9 Apr 2024
0:37
Upcoming studies investigating linvoseltamab in myeloma
Faith Davies • 9 Apr 2024
3:23
Molecular characteristics associated with increased risk of disease progression in SMM
Mark Bustoros • 27 Sep 2023
The content of VJHemOnc is intended for healthcare professionals